Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(29)
•••
Comment by elgin1on Jun 22, 2020 4:32pm
133 Views
Post# 31178247

RE:RE:RE:Are we seeing a bottom?

RE:RE:RE:Are we seeing a bottom?Red you are correct 35 cent warrant, and Million is not due til Dec 22.

Woundedknee :   we are having a pullback and basing around 24 to 25 cents.  Probably trade sideways until there is any news or updates imo.

But you need to have a core position because if there is any potential news and it is halted , it could open up much higher unless all you care about is trading and you resume momentum trading at the higher price once things settle.  Downside: 20 cents if there is no news over a prolonged period of time.  Expiry of warrants in july could make things interesting imo.

Anybody want to talk about how the histological slides looked incredible. Wonderful slides of islets, capillary formation on multiple patients.  As far as I am concerned the pouch is not a one trick pony and is viable.  Just wondering when and how management will release results.

Anything below 25 is great place to add to your position imo.  Bioteck keep them honest.

Elgin
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities